Related Experiment Video
Updated: Jul 19, 2026
09:00
Quantifying Pain Location and Intensity with Multimodal Pain Body Diagrams
Published on: July 7, 2023
Paediatric pain: a year in review
1Dalhousie University, IWK Grace Health Centre, 5850 University Avenue, Halifax, Nova Scotia, Canada B3J 3G9. allen.finley@dal.ca
Current Opinion in Anaesthesiology
|October 3, 2006
Summary
Recent advances in pediatric pain management focus on neonatal pain and assessment, alongside progress in opioid and non-opioid medications. Preemptive analgesia in children remains an area of ongoing research and understanding.
Area of Science:
- Pediatric Pain Management
- Anesthesiology
- Neonatal Care
Background:
- Significant progress has been made in understanding and managing pain in children.
- Recent years have seen major breakthroughs in neonatal pain research and assessment techniques.
Purpose of the Study:
- To review recent advancements in pediatric pain measurement, prevention, and treatment.
- To highlight key developments in neonatal pain and assessment, and pharmacological interventions for children.
Main Methods:
- Literature review of recent studies on pediatric pain management.
- Synthesis of findings on neonatal pain, pain assessment, and pharmacotherapy in children.
Main Results:
- Advances in neonatal pain and assessment have been particularly notable.
- Progress has been made in the clinical application of both opioid and non-opioid analgesics for pediatric use.
- The concept and practical application of preemptive analgesia in children are still under investigation.
Conclusions:
- While pharmacological treatments for pediatric pain have advanced, neonatal pain and assessment represent a frontier of discovery.
- Further research is needed to clarify the role and implementation of preemptive analgesia in pediatric care.
More Related Videos
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...